Jonben Svoboda, MD
Endocrinology, Diabetes & Metabolism · Springfield, MONPI 1831198993
Payments from drug & device makers
Across 492 payments — averaging $287.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$90K
- Johnson & Johnson$37K
- AstraZeneca$10K
- Abbott$721
- Amgen$603
- Dexcom, Inc.$498
- plus $2K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 134 | $90,290 |
| Johnson & Johnson | 59 | $37,099 |
| AstraZeneca | 31 | $9,866 |
| Abbott | 42 | $721 |
| Amgen | 33 | $603 |
| Dexcom, Inc. | 42 | $498 |
| Boehringer Ingelheim | 23 | $383 |
| Sanofi-aventis U.S. LLC | 25 | $303 |
| Pfizer | 19 | $264 |
| Lilly USA, LLC | 15 | $224 |
| Insulet Corporation | 4 | $210 |
| Antares Pharma, Inc. | 7 | $99 |
| Tandem Diabetes Care, Inc. | 2 | $90 |
| Radius Health, Inc. | 4 | $79 |
| Novartis | 5 | $76 |
| Amarin Pharma, Inc. | 3 | $63 |
| Xeris Pharmaceuticals, Inc. | 3 | $63 |
| Shire North American Group Inc | 5 | $59 |
| AbbVie | 4 | $56 |
| Kowa Pharmaceuticals America, Inc. | 4 | $53 |
| Bayer | 3 | $48 |
| Recordati_rare_diseases_inc. | 2 | $45 |
| Merck | 3 | $43 |
| Eisai Inc. | 2 | $41 |
| Corcept Therapeutics | 2 | $34 |
| Medtronic | 2 | $30 |
| Valeritas, Inc. | 2 | $30 |
| Aegerion Pharmaceuticals, Inc. | 2 | $24 |
| Intuity Medical Inc | 1 | $24 |
| Alvogen Inc | 1 | $23 |
| Cequr Corporation | 1 | $23 |
| BETA Bionics, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
| GSK | 1 | $11 |
| Clarus Therapeutics Inc. | 1 | $6 |
How this compares
$141,568 in reported general payments places this provider in the 90th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.
See all endocrinology, diabetes & metabolism providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Springfield
- Ralph DudaSpringfield$3M
- Gregory LedgerSpringfield$690K
- James BonucchiSpringfield$128K
- Thomas NickolasSaint Louis$945K
- Anne GoldbergSaint Louis$830K
- Janet McGillSaint Louis$828K
- Christopher CaseJefferson City$692K
- Karen Chang-ChenChesterfield$640K
- Alan RaubaJefferson City$594K
- Julie SilversteinSaint Louis$536K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.